Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity

Journal of Clinical Investigation

Volumn 120, Issue 11, 2010, Pages 4111-4117

  Yamagami, Jun ^a   Payne, Aimee S ^a   Kacir, Stephen ^a   Ishii, Ken ^b   Siegel, Don L ^a   Stanley, John R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DESMOGLEIN; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONSENSUS SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PATHOGENICITY; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PHAGE DISPLAY; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; COMPLEMENTARITY DETERMINING REGIONS; DESMOGLEINS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEMPHIGUS;

EID: 78049440518     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44425     Document Type: Article

References (29)

1. Stanley JR, Amagai M. Pemphigus, bullous impetigo, and staphylococcal scalded skin syndrome. N Engl J Med. 2006;355(17):1800-1810.
2. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest. 1999;103(4):461-468.
3. Stanley JR. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest. 1989;83(5):1443-1448.
4. Schiltz JR, Michel B. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol. 1976;67(2):254-260.
5. Hashimoto K, Shafran KM, Webber PS, Lazarus GS, Singer KH. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J Exp Med. 1983;157(1):259-272.
6. Rock B, Labib RS, Diaz LA. Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest. 1990;85(1):296-299. (Pubitemid 20030322)
7. Payne AS, et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest. 2005;115(4):888-899.
8. Ishii K, Lin C, Siegel DL, Stanley JR. Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies. J Invest Dermatol. 2008;128(4):939-948.
9. Yamagami J, Kacir S, Ishii K, Payne AS, Siegel DL, Stanley JR. Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus. J Immunol. 2009;183(9):5615-5621.
10. Stanley JR. Pemphigus. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, eds. Fitzpatrick's Dermatology in General Medicine. New York, New York, USA: McGraw-Hill; 2008:459-468.
11. Joly P, et al. A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med. 2007;357(6):545-552.
12. Mouquet H, et al. B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses. J Invest Dermatol. 2008;128(12):2859- 2869.
13. Qian Y, Diaz LA, Ye J, Clarke SH. Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients. J Immunol. 2007;178(9):5982-5990. (Pubitemid 46674396)
14. Brooks CL, et al. The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen. Glycobiology. 2010;20(2):138-147.
15. Schelonka RL, et al. Preferential use of DH reading frame 2 alters B cell development and antigen- specific antibody production. J Immunol. 2008;181(12):8409-8415.
16. Xu JL, Davis MM. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity. 2000;13(1):37-45.
17. Tsunoda K, et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol. 2003;170(4):2170-2178.
18. Ota T, Aoki-Ota M, Tsunoda K, Nishikawa T, Koyasu S, Amagai M. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance. Int Immunol. 2008;20(10):1351-1360.
19. Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, Amagai M. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the Nterminal adhesive region of desmogleins. J Immunol. 2001;167(9):5439-5448. (Pubitemid 33009785)
20. Kottke MD, Delva E, Kowalczyk AP. The desmosome: cell science lessons from human diseases. J Cell Sci. 2006;119(pt 5):797-806.
21. Yin T, Green KJ. Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol. 2004;15(6):665-677.
22. Waschke J. The desmosome and pemphigus. Histochem Cell Biol. 2008;130(1):21-54.
23. Qian Y, Clarke SH, Aoki V, Hans-Filhio G, Rivitti EA, Diaz LA. Antigen selection of anti-DSG1 autoantibodies during and before the onset of endemic pemphigus foliaceus. J Invest Dermatol. 2009;129(12):2823-2834.
24. Alam SM, et al. Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Proc Natl Acad Sci U S A. 2009;106(48):20234-20239.
25. Shapiro L, et al. Structural basis of cell-cell adhesion by cadherins. Nature. 1995;374(6520):327-337.
26. Boggon TJ, Murray J, Chappuis-Flament S, Wong E, Gumbiner BM, Shapiro L. C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science. 2002;296(5571):1308-1313.
27. Nagar B, Overduin M, Ikura M, Rini JM. Structural basis of calcium-induced E-cadherin rigidification and dimerization. Nature. 1996;380(6572):360-364. (Pubitemid 26097119)
28. Barbas CFI, Burton DR, Scott JK, Silverman GJ. Phage Display: A Laboratory Manual. Cold Spring Harbor, New York, USA: Cold Spring Harbor Laboratory Press; 2001.
29. Barbas CF III, Bain JD, Hoekstra DM, Lerner RA. Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc Natl Acad Sci U S A. 1992;89(1):4457-4461.